Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT00659204
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years old
* Ability to read and understand English (for consent purposes)
* Free of clinically evident dermatitis, open wounds, sores, or breaks in hand skin determined by a Visual Skin Scale (VSS).
* Free of hand jewelry or artificial nail enhancements
* Have fingernails that are clean and extend no longer than approximately one (1) mm past the nail bed
Exclusion Criteria:
* Anyone directly working in a healthcare, public health, or long term residence setting.
* Currently receiving any antibiotics, or on any other in as investigational drug, steroids or immunosuppressive therapy.
* Reports cuts, scratches, or skin disorders, or Dermatitis visualized by the PI/AI using the Visual Skin Scale (VSS).
* Reports any form of current immune disorders such as AIDS, lupus, any cancers (solid or hematopoietic), or other medical conditions such as diabetes, hepatitis, rheumatoid arthritis, or an organ transplant recipient.
* Known sensitivities or allergies to silver, alcohol, latex, soap, detergent, antibiotics.
* Any use of artificial nail enhancements or any non-removable rings
* Primary care provider or resident in a setting where someone has known impaired immunocompetence (currently receiving chemotherapy, HIV positive), requires wound care or intravenous management.
* Currently pregnant/lactating or taking care of children under the age of 3 or anyone that requires diaper changing.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00659204
Study Brief:
Protocol Section:
NCT00659204